AI-based software solution that analyzes 10-second normal sinus rhythm ECG data to predict atrial fibrillation risk and identify patients at potential risk for arrhythmia development. The system provides quantified risk assessment to support clinical decision-making for early detection and preventiv...
Manufactured by
DeepCardio Co. LTD.
South Korea
DeepCardio leverages AI-driven analysis of ECG (electrocardiogram) data to detect heart diseases. Founded in 2020, we have co-developed with leading medical centers. We received MFDS (Ministry of Food and Drug Safety) approval in 2024 for our AF (Atrial Fibrillation) AI-ECG solution. As we pursuing MFDS approval for solutions of CV (cardiovascular) risk and EF estimation, we are evloving into a cardiology-focused vertical AI company.
© 2026 Suplivia · Home · Browse Products